ABSTRACT
Background Semiquantitative grading of the vertebral body (SQ) is an easy screening method for vertebral body deformation. The validity of the SQ as a risk factor and as a screening tool for incident osteoporotic fractures (OF) was investigated using retrospective case-control data
Methods Outpatients followed up for ≥ two years as patients with osteoporosis were recruited. All of them were tested with X-ray images of the lateral thoracolumbar view and other tests at baseline. Patients were classified according to the SQ grade, and potential risk factors were compared for each SQ group. Cox regression analyses were conducted regarding the incident OFs separated into vertebral and non-vertebral fractures (VF and NVF). Statistical differences in the possible risk factors among the groups were examined, and the likelihood of the incident OFs in the variables was examined. After propensity score matching procedures of the confounding factors (PSM), the possibility of incident VFs was compared between the SQ grade groups.
Results In the crude dataset, the probabilities of incident VF in SQ Grade 3 and NVF in SQ Grade 1 or higher were significantly higher than in the other grades. Using a Cox regression analysis multivariant mode, the SQ grade was the only statistically significant factor for an incident VF, but not for NVF. However, no significant difference was shown after PSM for VFs.
Conclusions These results suggested that the SQ classification was inappropriate for predicting an incident OFs. However, the grading showed significantly higher risk, therefore that is available for screening.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Medical Corporation Genyu ethics committee approves this study protocol to match the clinical study standards and STROBE. The subjects and their families were informed that the personal information obtained in this study was anonymous and would only be used for analysis. They signed up with signatures as an agreement between the study participants. Study participants did not include minors.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
Conflict of Interest Statement: Ichiro Yoshii, Naoya Sawada, and Tatsumi Chijiwa declare no conflict of interest.
Ethical statement The study protocols and patient consent requirements were approved by the Ethics Committee of the Genyu Medical Corporation (approval number: G-2023-3). The subjects and their families were informed that the personal information obtained in this study was anonymous and would only be used for analysis.
Consent for publication: None
Availability of data and material: The datasets used and analyzed during the current study are available from the corresponding author upon reasonable request.
Code availability: Not applicable
English editing support and Use of AI application statement The authors ordered a grammar check for the professional English editor who works with Enago, an English editing company. They did not use AIGC tools to assist with writing.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.